The Business Times
business-time-50

Series C funding sends Biofourmis to near-unicorn status

Published Thu, Sep 3, 2020 · 09:50 PM

    Singapore

    HOMEGROWN startup Biofourmis has raised US$100 million in a Series C equity round led by Softbank Vision Fund 2, catapulting the healthcare company to near-unicorn status in a matter of months.

    The latest funding, which sources said has quadrupled Biofourmis' valuation from about US$200 million previously, comes despite a slowdown in healthcare investments in the Asia-Pacific over the first half of the year.

    BiofourmisSoftBankStartup fundingSeries C

    TRENDING NOW

    Ang Fung Fung (left) and Chew Hock Yong will join as independent non-executive directors on Nov 1.

    ComfortDelGro appoints two new independent directors

    Malaysian Chinese bag-maker Liew Bin now sees value in protectionist measures as low-cost competition from China threatens Malaysian small and medium-sized enterprises.

    Once staunchly pro-China, Malaysian Chinese businesses are now distancing themselves from Beijing

    The group reported a loss of S$2.55 million for the financial year ended Jun 30, and used S$2.16 million in cash in its operations. 

    NoonTalk needs continued financial support from CEO Dasmond Koh, auditors warn

    DP Architects’ CEO, Seah Chee Huang, says the firm is prototyping what it calls a “sustainability AI agent”. 

    DP Architects sets the benchmark for sustainability disclosure and design

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More